Delivery Order SPE2DB25D3110-SPE2DB26FTCCK
Award Date 10/20/25
Potential Completion Date 10/21/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 50 mg tablet UD (unit dose) 60s with a ceiling value of $1,436.15 under a firm fixed-price contract type. The award was made on April 24, 2025, with an ultimate completion date of April 25, 2025. This delivery order was not set-aside and represents a competitive award to the vendor's Corporate Office division, located in Conshohocken, Pennsylvania. VIMPAT (lacosamide) is a neurological...
- The Defense Logistics Agency awarded a delivery order valued at $1,874.60 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/mL solution in a 200 mL quantity. This contract, which was competitively awarded without a set-aside designation, represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. VIMPAT (lacosamide) is an antiepileptic medication used to treat partial-onset seizures, reflecting the critical pharmaceutical supply needs of federal military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of VIMPAT 100 mg at a ceiling value of $1,089.84 under a firm fixed price contract type. This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.04 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of VIMPAT 10 mg/ml Solution in 200ml quantities. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. VIMPAT (lacosamide) is a prescription anticonvulsant medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of VIMPAT 200 MG tablets in a quantity of 60 units, with a contract ceiling value of $1,089.82. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract has an ultimate completion date of July 28, 2025, and AmerisourceBergen will perform this work from its corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,310.40 for VIMPAT 10 mg/mL Solution in a 200 mL quantity, with an ultimate completion date of August 20, 2025. This is a firm fixed price, non-set-aside contract awarded on August 19, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. VIMPAT (lacosamide) is an antiepileptic medication used in the treatment of seizure disorders. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of VIMPAT 200 mg/20 ml vials valued at $1,365.00. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of VIMPAT 10 mg/mL solution in 200 mL quantities, valued at $1,959.86. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,689.20 to AmerisourceBergen Drug Corp for VIMPAT 200 mg tablets (60-count supply). This competitive, non-set-aside contract was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, under firm fixed-price terms. This delivery order is a child contract issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIMPAT 100 MG TABLET 60S for a total ceiling value of $1,484.97. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver...